{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:35:44Z","timestamp":1782452144801,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":50,"publisher":"Springer US","isbn-type":[{"value":"9781071627877","type":"print"},{"value":"9781071627884","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2788-4_9","type":"book-chapter","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T13:04:40Z","timestamp":1666098280000},"page":"129-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of HDACi-Coupled Nanoparticles: Opportunities and Challenges"],"prefix":"10.1007","author":[{"given":"Marie","family":"K\u00fchne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Cseresny\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Dzierza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Godmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Koschella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eggeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Thilo","family":"Figge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Heinzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.576946","volume":"8","author":"G Li","year":"2020","unstructured":"Li G, Tian Y, Zhu WG (2020) The roles of histone deacetylases and their inhibitors in cancer therapy. Front Cell Dev Biol 8:576946","journal-title":"Front Cell Dev Biol"},{"issue":"Suppl","key":"9_CR2","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.ijantimicag.2013.04.004","volume":"42","author":"E Ciarlo","year":"2013","unstructured":"Ciarlo E, Savva A, Roger T (2013) Epigenetics in sepsis: targeting histone deacetylases. Int J Antimicrob Agents 42(Suppl):S8\u2013S12","journal-title":"Int J Antimicrob Agents"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/icb.2011.92","volume":"90","author":"BA Suliman","year":"2012","unstructured":"Suliman BA, Xu D, Williams BR (2012) HDACi: molecular mechanisms and therapeutic implications in the innate immune system. Immunol Cell Biol 90:23\u201332","journal-title":"Immunol Cell Biol"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/med.21701","volume":"40","author":"DA Rodrigues","year":"2020","unstructured":"Rodrigues DA, Pinheiro PSM, Sagrillo FS et al (2020) Histone deacetylases as targets for the treatment of neurodegenerative disorders: challenges and future opportunities. Med Res Rev 40:2177\u20132211","journal-title":"Med Res Rev"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2174\/0929867325666181016163110","volume":"27","author":"L Cappellacci","year":"2020","unstructured":"Cappellacci L, Perinelli DR, Maggi F et al (2020) Recent progress in histone deacetylase inhibitors as anticancer agents. Curr Med Chem 27:2449\u20132493","journal-title":"Curr Med Chem"},{"key":"9_CR6","doi-asserted-by":"crossref","unstructured":"Li Y, Seto E (2016) HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med 6","DOI":"10.1101\/cshperspect.a026831"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"A Suraweera","year":"2018","unstructured":"Suraweera A, O\u2019byrne KJ, Richard DJ (2018) Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front Oncol 8:92","journal-title":"Front Oncol"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mabi.201300213","volume":"14","author":"D Hennig","year":"2014","unstructured":"Hennig D, Schubert S, Dargatz H et al (2014) Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors. Macromol Biosci 14:69\u201380","journal-title":"Macromol Biosci"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s12010-011-9383-z","volume":"165","author":"A Fernandez-Fernandez","year":"2011","unstructured":"Fernandez-Fernandez A, Manchanda R, Mcgoron AJ (2011) Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol 165:1628\u20131651","journal-title":"Appl Biochem Biotechnol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1039\/c2cs15294k","volume":"41","author":"R Mout","year":"2012","unstructured":"Mout R, Moyano DF, Rana S et al (2012) Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 41:2539\u20132544","journal-title":"Chem Soc Rev"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/17460441.2020.1750591","volume":"15","author":"FLO Da Silva","year":"2020","unstructured":"Da Silva FLO, Marques MBF, Kato KC et al (2020) Nanonization techniques to overcome poor water-solubility with drugs. Expert Opin Drug Discovery 15:853\u2013864","journal-title":"Expert Opin Drug Discovery"},{"key":"9_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202000039","volume":"20","author":"H Lindemann","year":"2020","unstructured":"Lindemann H, K\u00fchne M, Grune C et al (2020) Polysaccharide nanoparticles bearing HDAC inhibitor as nontoxic nanocarrier for drug delivery. Macromol Biosci 20:e2000039","journal-title":"Macromol Biosci"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jconrel.2020.10.006","volume":"329","author":"M K\u00fchne","year":"2021","unstructured":"K\u00fchne M, Lindemann H, Grune C et al (2021) Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity. J Control Release 329:717\u2013730","journal-title":"J Control Release"},{"key":"9_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120567","volume":"601","author":"M K\u00fchne","year":"2021","unstructured":"K\u00fchne M, Kretzer C, Lindemann H et al (2021) Biocompatible valproic acid-coupled nanoparticles attenuate lipopolysaccharide-induced inflammation. Int J Pharm 601:120567","journal-title":"Int J Pharm"},{"key":"9_CR15","doi-asserted-by":"crossref","unstructured":"Bernal-Chavez SA, Del Prado-Audelo ML, Caballero-Floran IH et al (2021) Insights into terminal sterilization processes of nanoparticles for biomedical applications. Molecules 26","DOI":"10.3390\/molecules26072068"},{"key":"9_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-45524-2","volume-title":"Handbook of biological confocal microscopy","author":"J Pawley","year":"2006","unstructured":"Pawley J (2006) Handbook of biological confocal microscopy. Springer"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrm.2017.71","volume":"18","author":"SJ Sahl","year":"2017","unstructured":"Sahl SJ, Hell SW, Jakobs S (2017) Fluorescence nanoscopy in cell biology. Nat Rev Mol Cell Biol 18:685\u2013701","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41556-018-0251-8","volume":"21","author":"L Schermelleh","year":"2019","unstructured":"Schermelleh L, Ferrand A, Huser T et al (2019) Super-resolution microscopy demystified. Nat Cell Biol 21:72\u201384","journal-title":"Nat Cell Biol"},{"key":"9_CR19","doi-asserted-by":"crossref","unstructured":"Reifarth M, Hoeppener S, Schubert US (2018) Uptake and intracellular fate of engineered nanoparticles in mammalian cells: capabilities and limitations of transmission electron microscopy-polymer-based nanoparticles. Adv Mater 30","DOI":"10.1002\/adma.201703704"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia E, Ehrlich M, Massol R et al (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839\u2013850","journal-title":"Dev Cell"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"9_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.201960079","volume":"13","author":"A Medyukhina","year":"2020","unstructured":"Medyukhina A, Figge MT (2020) DeconvTest: simulation framework for quantifying errors and selecting optimal parameters of image deconvolution. J Biophotonics 13:e201960079","journal-title":"J Biophotonics"},{"key":"9_CR24","volume-title":"Guided- deconvolution in correlative light and electron microscopy","author":"M Fengjiao","year":"2021","unstructured":"Fengjiao M, Sedzicki J, Hoeppener S et al (2021) Guided- deconvolution in correlative light and electron microscopy. ELMI"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1109\/TMAG.2012.2222635","volume":"49","author":"F Bahring","year":"2013","unstructured":"Bahring F, Schlenk F, Wotschadlo J et al (2013) Suitability of viability assays for testing biological effects of coated superparamagnetic nanoparticles. IEEE Trans Magn 49:383\u2013388","journal-title":"IEEE Trans Magn"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s00204-017-1968-z","volume":"91","author":"F Schlenk","year":"2017","unstructured":"Schlenk F, Werner S, Rabel M et al (2017) Comprehensive analysis of the in vitro and ex ovo hemocompatibility of surface engineered iron oxide nanoparticles for biomedical applications. Arch Toxicol 91:3271\u20133286","journal-title":"Arch Toxicol"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1021\/cr2002596","volume":"112","author":"M Mahmoudi","year":"2012","unstructured":"Mahmoudi M, Hofmann H, Rothen-Rutishauser B et al (2012) Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev 112:2323\u20132338","journal-title":"Chem Rev"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","volume-title":"Biotechnology annual review","author":"MV Berridge","year":"2005","unstructured":"Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. In: Biotechnology annual review. Elsevier, pp 127\u2013152"},{"key":"9_CR29","unstructured":"Anonymous (2017) ISO 10993-4: biological evaluation of medical devices\u2013Part 4: Selection of tests for interactions with blood. In: Standardization IOf (ed)"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/mabi.201200017","volume":"12","author":"M Bauer","year":"2012","unstructured":"Bauer M, Lautenschlaeger C, Kempe K et al (2012) Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility. Macromol Biosci 12:986\u2013998","journal-title":"Macromol Biosci"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1590\/S1516-14392007000100008","volume":"10","author":"AV Cardoso","year":"2007","unstructured":"Cardoso AV, Pereira MH, Marcondes GDA et al (2007) Microplate reader analysis of triatomine saliva effect on erythrocyte aggregation. Mater Res 10:31\u201336","journal-title":"Mater Res"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"8339","DOI":"10.1039\/c3cs60145e","volume":"42","author":"F Joris","year":"2013","unstructured":"Joris F, Manshian BB, Peynshaert K et al (2013) Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro\u2013in vivo gap. Chem Soc Rev 42:8339\u20138359","journal-title":"Chem Soc Rev"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3382\/ps.0530409","volume":"53","author":"BE Dunn","year":"1974","unstructured":"Dunn BE (1974) Technique for shell-less culture of the 72-hour avian embryo. Poult Sci 53:409\u2013412","journal-title":"Poult Sci"},{"key":"9_CR34","first-page":"199","volume":"11","author":"M Rosenbruch","year":"1994","unstructured":"Rosenbruch M (1994) Early stages of the incubated chicken egg as a model in experimental biology and medicine. ALTEX-Altern Anim Exp 11:199\u2013206. (Article in German)","journal-title":"ALTEX-Altern Anim Exp"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/nanoph-2018-0219","volume":"8","author":"FF Zheng","year":"2019","unstructured":"Zheng FF, Xiong WW, Sun SS et al (2019) Recent advances in drug release monitoring. Nanophotonics-Berlin 8:391\u2013413","journal-title":"Nanophotonics-Berlin"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978","journal-title":"EMBO J"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1128\/MCB.22.22.7820-7830.2002","volume":"22","author":"C Hauser","year":"2002","unstructured":"Hauser C, Schuettengruber B, Bartl S et al (2002) Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol Cell Biol 22:7820\u20137830","journal-title":"Mol Cell Biol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","volume":"22","author":"OH Kr\u00e4mer","year":"2003","unstructured":"Kr\u00e4mer OH, Zhu P, Ostendorff HP et al (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22:3411\u20133420","journal-title":"EMBO J"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1080\/17425247.2017.1285280","volume":"14","author":"E Mauri","year":"2017","unstructured":"Mauri E, Papa S, Masi M et al (2017) Novel functionalization strategies to improve drug delivery from polymers. Expert Opin Drug Deliv 14:1305\u20131313","journal-title":"Expert Opin Drug Deliv"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fcell.2020.00400","volume":"8","author":"B Tu","year":"2020","unstructured":"Tu B, Zhang M, Liu T et al (2020) Nanotechnology-based histone deacetylase inhibitors for cancer therapy. Front Cell Dev Biol 8:400","journal-title":"Front Cell Dev Biol"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","volume":"141","author":"R Bazak","year":"2015","unstructured":"Bazak R, Houri M, El Achy S et al (2015) Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 141:769\u2013784","journal-title":"J Cancer Res Clin Oncol"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1016\/j.biomaterials.2011.06.024","volume":"32","author":"S Luo","year":"2011","unstructured":"Luo S, Zhang E, Su Y et al (2011) A review of NIR dyes in cancer targeting and imaging. Biomaterials 32:7127\u20137138","journal-title":"Biomaterials"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1038\/ncomms6565","volume":"5","author":"AT Press","year":"2014","unstructured":"Press AT, Traeger A, Pietsch C et al (2014) Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles. Nat Commun 5:5565","journal-title":"Nat Commun"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson R, Broglie JJ, Adcock AF et al (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12:207\u2013218","journal-title":"Assay Drug Dev Technol"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni F, Reynaud EG, Stelzer EH (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8:839\u2013845","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jcp.24683","volume":"230","author":"M Ravi","year":"2015","unstructured":"Ravi M, Paramesh V, Kaviya SR et al (2015) 3D cell culture systems: advantages and applications. J Cell Physiol 230:16\u201326","journal-title":"J Cell Physiol"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7021-6_1","volume":"1612","author":"Z Koledova","year":"2017","unstructured":"Koledova Z (2017) 3D cell culture: an introduction. Methods Mol Biol 1612:1\u201311","journal-title":"Methods Mol Biol"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","volume":"19","author":"A Sontheimer-Phelps","year":"2019","unstructured":"Sontheimer-Phelps A, Hassell BA, Ingber DE (2019) Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer 19:65\u201381","journal-title":"Nat Rev Cancer"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","volume":"21","author":"D Huh","year":"2011","unstructured":"Huh D, Hamilton GA, Ingber DE (2011) From 3D cell culture to organs-on-chips. Trends Cell Biol 21:745\u2013754","journal-title":"Trends Cell Biol"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrd4539","volume":"14","author":"EW Esch","year":"2015","unstructured":"Esch EW, Bahinski A, Huh D (2015) Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov 14:248\u2013260","journal-title":"Nat Rev Drug Discov"}],"container-title":["Methods in Molecular Biology","HDAC\/HAT Function Assessment and Inhibitor Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2788-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T13:05:43Z","timestamp":1666098343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2788-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"ISBN":["9781071627877","9781071627884"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2788-4_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"19 October 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}